Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis

OBJECTIVE: To investigate the effects of long-term treatment with bosentan on pulmonary arterial hypertension (PAH) in patients with systemic sclerosis. METHODS: Patients with systemic sclerosis were followed between 2003 and 2014; those who developed digital ulcers were treated with standard regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdaca, Giuseppe, Lantieri, Francesca, Puppo, Francesco, Bezante, Gian Paolo, Balbi, Manrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Immuno-Mediated Diseases and CV Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536521/
https://www.ncbi.nlm.nih.gov/pubmed/27683147
http://dx.doi.org/10.1177/0300060515593257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536521/
https://www.ncbi.nlm.nih.gov/pubmed/27683147
http://dx.doi.org/10.1177/0300060515593257

Ejemplares similares